Increased COX-2/PGE2/EP3 signaling has long been observed in hypertensive patients and animals, and inhibition of the signaling pathway attenuates vascular remodeling in hypertension [13, 14]. The gene discussed is PTGS2; the disease is hypertensive disorder.